AML with RUNX1-RUNX1T1, AML with some KMT2A fusions, and AML with three mutations (in NPM1, DNMT3A, and FLT3) together were also associated with mRNA and miRNA expression signatures. Here, FLT3 is linked to acute myeloid leukemia.